{
  "docId": "019de075-c130-77ea-b60f-b21955e0fc8e",
  "docSlug": "71c1598fd07d494c4a73d86584bdcfa9",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 6,
  "pageCount": 39,
  "prevPage": 5,
  "nextPage": 7,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a Venn diagram to illustrate the intersection of Kinase Resistance and Kinase Selectivity.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-c130-77ea-b60f-b21955e0fc8e/6",
  "deckHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e",
  "deckJsonHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e.json",
  "deckAnchorHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e#slide-6",
  "components": [
    {
      "bbox": {
        "h": 0.8,
        "w": 0.45,
        "x": 0.5,
        "y": 0.1
      },
      "kind": "diagram",
      "text": "Venn diagram showing the intersection of Kinase Resistance and Kinase Selectivity",
      "attrs": null,
      "subkind": "venn",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f630eae-266a-438a-95e0-616fb1ce7107",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.4,
        "x": 0.07,
        "y": 0.55
      },
      "kind": "list",
      "text": "Expertise in structure-based drug design to create innovative small molecules. \"Threading the needle\": Aim to achieve high affinity for drug-resistant kinases while avoiding off-target kinases. Potential to minimize adverse events AND drive more durable responses",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "6395588c-ad8d-46d0-9c1c-cedf96843fe3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.07,
        "y": 0.35
      },
      "kind": "paragraph",
      "text": "Nuvalent is focused on creating precisely targeted therapies to overcome key limitations of existing therapies for clinically proven kinases and renew hope for patients in need",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "f256f156-b4bd-45ef-8f46-ffe10f0c24ea",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.07,
        "y": 0.12
      },
      "kind": "title",
      "text": "PRECISELY Targeted Therapies for patients with cancer",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "45450f7f-3658-4564-9850-13268b591e2f",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Venn diagram",
      "slug": "venn-diagram",
      "agent": null,
      "layer": "slide",
      "matchId": "d0b5c8ee-2541-4993-8b7c-4817b07c0702",
      "evidence": "diagram/venn: Venn diagram showing the intersection of Kinase Resistance and Kinase Selectivity",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "venn",
      "slug": null,
      "matchId": "d8c55ff4-f93f-4877-bd46-c69d1cf53245",
      "evidence": "Visual intersection of two concepts",
      "confidence": 1
    }
  ],
  "arcBeats": [
    {
      "to": 6,
      "from": 6,
      "beatId": "af08a215-8bda-49a9-b4de-9eba972cf7ae",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution of precisely targeted therapies is introduced.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 9,
      "from": 6,
      "name": "Jobs To Be Done",
      "slug": "53-jobs-to-be-done",
      "bestFor": "Product innovation, market entry, competitive positioning",
      "matchId": "7d073297-3453-4a5f-a314-d600119c06ad",
      "evidence": "The need for precisely targeted therapies is discussed.",
      "position": 2,
      "objective": "What are the unmet needs in cancer treatment?",
      "structure": "The Customer's Job -> Current Solutions (Hired/Fired) -> Unmet Needs -> Our Solution Fit",
      "confidence": 0.6,
      "description": "Reframe the problem around what the customer is trying to accomplish, not what they're buying"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}